Company Search:
Advanced Search
Sponsored Links
CEL-SCI Corporation Company Snapshot
CEL-SCI Corporation operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares CEL-SCI with three other companies in this sector in the United States: Idera Pharmaceuticals, Inc. (2018 sales of $662,000.00 of which 100% was Novel Therapeutics), Trovagene Inc ($378,325.00 of which 100% was Biological Product), and AIM ImmunoTech Inc ($367,000.00 ).

Sales Analysis. Sales increased substantially in 2018: CEL-SCI reported sales of $476,556.00 for the fiscal year ending September of 2018. This represents an increase of 590.5% versus 2017, when the company's sales were $69,020.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
CEL-SCI Corporation
  Stock Performance Chart for CEL-SCI Corporation
  Stock Data: Recent Stock Performance:
  Current Price (9/20/2019): 8.48
(Figures in U.S. Dollars)
1 Week 5.1%   13 Weeks 7.9%  
4 Weeks 5.6%   52 Weeks 121.4%  
CEL-SCI Corporation Key Data:
  Ticker: CVM Country: United States
  Exchanges: ASE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 476,556
(Year Ending Jan 2019).
Employees: 41
  Currency: U.S. Dollars Market Cap: 285,800,185
  Fiscal Yr Ends: September Shares Outstanding: 33,702,852
  Share Type: Common Closely Held Shares: 1,641,964
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.